Skip to content
HowShorted

Acorda Therapeutics, Inc. short interest in 2021

In 2021, Acorda Therapeutics, Inc.'s disclosed short interest ran from 11.26% of shares outstanding on 15 Mar 2021 to 8.40% on 30 Nov 2021, a change of -2.86 percentage points. The year's high was 15.10% on 28 May 2021 and its low 3.80% on 15 Oct 2021, averaging 9.21% across 18 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 11.15 days on 28 May 2021. Full history: Acorda Therapeutics, Inc..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023 · 2024

Aggregate net short position time series for Acorda Therapeutics, Inc. in 2021

2021 in figures

Start of year
11.26% (15 Mar 2021)
End of year
8.40% (30 Nov 2021)
Change
-2.86 pp
High
15.10% (28 May 2021)
Low
3.80% (15 Oct 2021)
Average
9.21%
Highest days to cover
11.15 (28 May 2021)
SEC filings marked
9

Every report in 2021

Acorda Therapeutics, Inc. short interest in 2021
SettlementShort interestDays to coverFilings since previous
15 Mar 202111.26%3.51results (8-K), results (8-K)
31 Mar 202112.23%7.6610-K filed
15 Apr 202113.09%7.39
30 Apr 202112.58%8.65
14 May 202112.75%9.10results (8-K), 10-Q filed
28 May 202115.10%11.15
15 Jun 20218.37%1.82
30 Jun 20217.12%1.72
15 Jul 20216.27%4.97
30 Jul 202112.52%1.00
13 Aug 202112.67%3.70results (8-K), 10-Q filed
31 Aug 20218.44%4.48
15 Sep 20216.81%4.98
30 Sep 20215.13%5.14
15 Oct 20213.80%4.03
29 Oct 20213.91%4.84
15 Nov 20215.24%3.31results (8-K), 10-Q filed
30 Nov 20218.40%3.84

See also: Acorda Therapeutics, Inc.'s full history · most shorted US stocks of 2021 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.